Omega Historical Cash Flow
| OHI Stock | USD 39.81 0.80 1.97% |
Analysis of Omega Healthcare cash flow over time is an excellent tool to project Omega Healthcare Inv future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 335.7 M or Other Non Cash Items of 30.7 M as it is a great indicator of Omega Healthcare ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Omega Healthcare Inv latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Omega Healthcare Inv is a good buy for the upcoming year.
Omega |
About Omega Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Omega balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Omega's non-liquid assets can be easily converted into cash.
Omega Healthcare Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Capital Expenditures
Capital Expenditures are funds used by Omega Healthcare Inv to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Omega Healthcare operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Omega Healthcare Inv financial statement analysis. It represents the amount of money remaining after all of Omega Healthcare Investors operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Omega Healthcare's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Omega Healthcare Inv current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, Omega Healthcare's Other Non Cash Items is decreasing as compared to previous years. The Omega Healthcare's current Total Cash From Operating Activities is estimated to increase to about 648.6 M, while Change In Working Capital is projected to decrease to (15.8 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Begin Period Cash Flow | 167.6M | 24.4M | 300.6M | 315.7M | End Period Cash Flow | 24.4M | 300.6M | 444.7M | 467.0M |
Omega Healthcare cash flow statement Correlations
Click cells to compare fundamentals
Omega Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Omega Healthcare cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 21.7M | 134.2M | (143.1M) | 276.2M | 144.1M | 151.3M | |
| Free Cash Flow | 414.1M | 633.1M | 627.1M | 625.7M | 617.7M | 648.6M | |
| Change In Working Capital | (124.1M) | (30.8M) | (94.0M) | (45.6M) | (15.1M) | (15.8M) | |
| Other Cashflows From Financing Activities | 89.2M | (35.4M) | 2.2B | 576.6M | 62.1M | 59.0M | |
| Depreciation | 301.7M | 329.9M | 342.0M | 332.4M | 319.7M | 335.7M | |
| Other Non Cash Items | 3.7M | (2.5M) | 35.1M | (127.2M) | 29.3M | 30.7M | |
| Dividends Paid | 564.1M | 612.3M | 637.6M | 632.9M | (643.9M) | (611.7M) | |
| Capital Expenditures | 139.7M | 75.1M | 95.1M | 247.1M | 38.0M | 36.1M | |
| Total Cash From Operating Activities | 553.7M | 708.3M | 722.1M | 625.7M | 617.7M | 648.6M | |
| Change To Account Receivables | (52.5M) | (23.3M) | (75.4M) | (58.0M) | (3.7M) | (3.8M) | |
| Net Income | 351.9M | 163.5M | 428.3M | 438.8M | 248.8M | 129.3M | |
| Total Cash From Financing Activities | (154.0M) | (485.5M) | (341.1M) | (789.4M) | (473.3M) | (449.6M) | |
| End Period Cash Flow | 33.4M | 167.6M | 24.4M | 300.6M | 444.7M | 467.0M | |
| Begin Period Cash Flow | 11.7M | 33.4M | 167.6M | 24.4M | 300.6M | 315.7M | |
| Sale Purchase Of Stock | 2.0B | 1.8B | (79K) | (152.0M) | (77K) | (73.2K) | |
| Total Cashflows From Investing Activities | (379.0M) | (89.1M) | (524.2M) | 442.9M | 398.6M | 418.5M | |
| Other Cashflows From Investing Activities | 167.8M | 176.7M | 324.5M | 690.0M | 793.5M | 833.1M | |
| Change To Netincome | (38.0M) | 84.7M | (70.0M) | (286.6M) | (257.9M) | (245.0M) | |
| Investments | 23.6M | (53.9M) | (92.8M) | 442.9M | 58.3M | 61.3M | |
| Net Borrowings | (167.0M) | (4.1M) | 47.8M | 7.7M | 6.9M | 6.6M | |
| Cash And Cash Equivalents Changes | 20.8M | 133.7M | (143.2M) | 279.1M | 321.0M | 337.1M | |
| Cash Flows Other Operating | (56.0M) | 144.3M | 31.3M | 146.7M | 168.7M | 111.1M | |
| Stock Based Compensation | 15.4M | 18.8M | 21.4M | 27.3M | 35.1M | 36.8M | |
| Change To Operating Activities | (29.3M) | 15.6M | (4.9M) | 6.5M | 5.8M | 6.1M | |
| Issuance Of Capital Stock | 404.9M | 152.8M | 274.0M | 8.1M | 330.0M | 228.3M |
Currently Active Assets on Macroaxis
When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.137 | Dividend Share 2.68 | Earnings Share 1.36 | Revenue Per Share 4.03 | Quarterly Revenue Growth 0.14 |
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.